Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thyroid Papillary Microtumor: Validation of the (Updated) Porto Proposal Assessing Sex Hormone Receptor Expression and Mutational BRAF Gene Status.

The American journal of surgical pathology - 1 Sept 2020

Aliyev Elvin, Ladra-González María J, Sánchez-Ares María, Abdulkader-Nallib Ihab, Piso-Neira Magalí, Rodríguez-Carnero Gemma, Vieiro-Balo Paula, Pérez-Becerra Raquel, Gude-Sampedro Francisco, Barreiro-Morandeira Francisco, Alvarez Clara V, Cameselle-Teijeiro José M

Abstract excerpt

Given the high incidence and excellent prognosis of many papillary thyroid microcarcinomas, the Porto proposal uses the designation papillary microtumor (PMT) for papillary microcarcinomas (PMCs) without risk factors to minimize overtreatment and patients' stress. To validate Porto proposal criteria, we examined a series of 190 PMC series, also studying sex hormone receptors and BRAF mutation. Our updated Porto...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Estrogen Receptor alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Receptor beta

Share to Radiotherapy, Adjuvant

Share to Receptors, Androgen

Share to Receptors, Progesterone

Share to Receptors, Steroid

Share to Thyroidectomy

Source

Identifiers

PMID: 32804453
DOI: 10.1097/PAS.0000000000001522

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thyroid Papillary Microtumor: Validation of the (Updated) Porto Proposal Assessing Sex Hormone Receptor Expression and Mutational BRAF Gene Status.PMID 32804453Read ↗

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.Semantic proximity Read ↗

BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.Semantic proximity Read ↗

Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings.Semantic proximity Read ↗

Risk factors associated with aggressive tumor phenotypes in papillary thyroid microcarcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies.Semantic proximity Read ↗

Papillary microcarcinoma of the thyroid gland: Evaluation of TERT and BRAFV-600E expression and their relationship with clinicopathological findings.Semantic proximity Read ↗

BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.Semantic proximity Read ↗

Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.Semantic proximity Read ↗

High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networksSemantic proximity Read ↗

The utility of BRAF testing in the management of papillary thyroid cancer.Semantic proximity Read ↗

Clinical and molecular features of progressive papillary thyroid microcarcinoma.Semantic proximity Read ↗

BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.